An interview with Dr Rudolf Widmann, CEO and Dr Christoph Klade, CSO about AOP Orphan’s commitment to sustainable innovation for the benefit of patients with rare diseases and Austria as a research location was published recently in CURE, a special edition insert for the Austrian newspaper “derStandard”.

To read the full article in German

please click